150 related articles for article (PubMed ID: 24409176)
1. Mathematical modeling of oncogenesis control in mature T-cell populations.
Gerdes S; Newrzela S; Glauche I; von Laer D; Hansmann ML; Roeder I
Front Immunol; 2013; 4():380. PubMed ID: 24409176
[TBL] [Abstract][Full Text] [Related]
2. An evolutionary stability perspective on oncogenesis control in mature T-cell populations.
Diebner HH; Kirberg J; Roeder I
J Theor Biol; 2016 Jan; 389():88-100. PubMed ID: 26549469
[TBL] [Abstract][Full Text] [Related]
3. Malignant transformation of mature T cells after gammaretrovirus mediated transfer of nucleophosmin-anaplastic lymphoma kinase oncogene.
Kumar A
Indian J Pathol Microbiol; 2015; 58(3):301-6. PubMed ID: 26275250
[TBL] [Abstract][Full Text] [Related]
4. Mature T-cell lymphomagenesis induced by retroviral insertional activation of Janus kinase 1.
Heinrich T; Rengstl B; Muik A; Petkova M; Schmid F; Wistinghausen R; Warner K; Crispatzu G; Hansmann ML; Herling M; von Laer D; Newrzela S
Mol Ther; 2013 Jun; 21(6):1160-8. PubMed ID: 23609016
[TBL] [Abstract][Full Text] [Related]
5. T-cell receptor diversity prevents T-cell lymphoma development.
Newrzela S; Al-Ghaili N; Heinrich T; Petkova M; Hartmann S; Rengstl B; Kumar A; Jäck HM; Gerdes S; Roeder I; Hansmann ML; von Laer D
Leukemia; 2012 Dec; 26(12):2499-507. PubMed ID: 22643706
[TBL] [Abstract][Full Text] [Related]
6. Mathematical modeling of helper T lymphocyte/antigen-presenting cell interactions: analysis of methods for modifying antigen processing and presentation.
Agrawal NG; Linderman JJ
J Theor Biol; 1996 Oct; 182(4):487-504. PubMed ID: 8944895
[TBL] [Abstract][Full Text] [Related]
7. Generation of CD20-specific TCRs for TCR gene therapy of CD20low B-cell malignancies insusceptible to CD20-targeting antibodies.
Jahn L; van der Steen DM; Hagedoorn RS; Hombrink P; Kester MG; Schoonakker MP; de Ridder D; van Veelen PA; Falkenburg JH; Heemskerk MH
Oncotarget; 2016 Nov; 7(47):77021-77037. PubMed ID: 27776339
[TBL] [Abstract][Full Text] [Related]
8. Retroviral insertional mutagenesis can contribute to immortalization of mature T lymphocytes.
Newrzela S; Cornils K; Heinrich T; Schläger J; Yi JH; Lysenko O; Kimpel J; Fehse B; von Laer D
Mol Med; 2011; 17(11-12):1223-32. PubMed ID: 21826372
[TBL] [Abstract][Full Text] [Related]
9. Resistance of mature T cells to oncogene transformation.
Newrzela S; Cornils K; Li Z; Baum C; Brugman MH; Hartmann M; Meyer J; Hartmann S; Hansmann ML; Fehse B; von Laer D
Blood; 2008 Sep; 112(6):2278-86. PubMed ID: 18566328
[TBL] [Abstract][Full Text] [Related]
10. Retrogenic modeling of experimental allergic encephalomyelitis associates T cell frequency but not TCR functional affinity with pathogenicity.
Alli R; Nguyen P; Geiger TL
J Immunol; 2008 Jul; 181(1):136-45. PubMed ID: 18566378
[TBL] [Abstract][Full Text] [Related]
11. Influenza virus-specific TCR-transduced T cells as a model for adoptive immunotherapy.
Berdien B; Reinhard H; Meyer S; Spöck S; Kröger N; Atanackovic D; Fehse B
Hum Vaccin Immunother; 2013 Jun; 9(6):1205-16. PubMed ID: 23428899
[TBL] [Abstract][Full Text] [Related]
12. Differential kinetics of antigen dependency of CD4+ and CD8+ T cells.
Rabenstein H; Behrendt AC; Ellwart JW; Naumann R; Horsch M; Beckers J; Obst R
J Immunol; 2014 Apr; 192(8):3507-17. PubMed ID: 24639353
[TBL] [Abstract][Full Text] [Related]
13. A unified model for T cell antigen recognition and thymic selection of the T cell repertoire.
Mannie MD
J Theor Biol; 1991 Jul; 151(2):169-92. PubMed ID: 1943141
[TBL] [Abstract][Full Text] [Related]
14. MHC-mismatched mixed chimerism mediates thymic deletion of cross-reactive autoreactive T cells and prevents insulitis in nonobese diabetic mice.
Racine JJ; Zhang M; Wang M; Morales W; Shen C; Zeng D
J Immunol; 2015 Jan; 194(1):407-17. PubMed ID: 25429069
[TBL] [Abstract][Full Text] [Related]
15. Endogenous co-expression of two T cell receptors promotes lymphopenia-induced proliferation via increased affinity for self-antigen.
Balakrishnan A; Jama B; Morris GP
J Leukoc Biol; 2018 Dec; 104(6):1097-1104. PubMed ID: 30168881
[TBL] [Abstract][Full Text] [Related]
16. Potential use of T cell receptor genes to modify hematopoietic stem cells for the gene therapy of cancer.
Clay TM; Custer MC; Spiess PJ; Nishimura MI
Pathol Oncol Res; 1999; 5(1):3-15. PubMed ID: 10079371
[TBL] [Abstract][Full Text] [Related]
17. The myeloma-associated oncogene fibroblast growth factor receptor 3 is transforming in hematopoietic cells.
Li Z; Zhu YX; Plowright EE; Bergsagel PL; Chesi M; Patterson B; Hawley TS; Hawley RG; Stewart AK
Blood; 2001 Apr; 97(8):2413-9. PubMed ID: 11290605
[TBL] [Abstract][Full Text] [Related]
18. Development of genetically engineered CD4+ and CD8+ T cells expressing TCRs specific for a M. tuberculosis 38-kDa antigen.
Luo W; Zhang XB; Huang YT; Hao PP; Jiang ZM; Wen Q; Zhou MQ; Jin Q; Ma L
J Mol Med (Berl); 2011 Sep; 89(9):903-13. PubMed ID: 21556811
[TBL] [Abstract][Full Text] [Related]
19. Concepts in mature T-cell lymphomas - highlights from an international joint symposium on T-cell immunology and oncology.
Herling M; Rengstl B; Scholtysik R; Hartmann S; Küppers R; Hansmann ML; Diebner HH; Roeder I; Abken H; Newrzela S; Kirberg J
Leuk Lymphoma; 2017 Apr; 58(4):788-796. PubMed ID: 27643643
[TBL] [Abstract][Full Text] [Related]
20. Enhanced interaction between SEC2 mutant and TCR Vβ induces MHC II-independent activation of T cells via PKCθ/NF-κB and IL-2R/STAT5 signaling pathways.
Fu X; Xu M; Song Y; Li Y; Zhang H; Zhang J; Zhang C
J Biol Chem; 2018 Dec; 293(51):19771-19784. PubMed ID: 30352872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
